FAS
TMO icon

Formuepleje A/S’s Thermo Fisher Scientific TMO Stock Holding History

Formuepleje A/S’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$62.7M Sell
125,121
-9,246
-7% -$4.44M 4.91% 7
2026
Q1 		$66M Sell
134,367
-18,636
-12% -$10.1M 5.99% 4
2025
Q4 		$88.7M Sell
153,003
-33,550
-18% -$19M 5.3% 3
2025
Q3 		$90.5M Sell
186,553
-4,008
-2% -$1.87M 5.11% 3
2025
Q2 		$94.8M Hold
190,561
– – 5.41% 4
2025
Q1 		$94.8M Sell
190,561
-9,167
-5% -$4.96M 5.41% 4
2024
Q4 		$104M Buy
199,728
+23,321
+13% +$12.8M 5.6% 3
2024
Q3 		$109M Sell
176,407
-2,294
-1% -$1.36M 5.58% 3
2024
Q2 		$98.8M Buy
178,701
+30,476
+21% +$17.5M 5.46% 2
2024
Q1 		$86.1M Buy
148,225
+21,931
+17% +$12.3M 4.87% 2
2023
Q4 		$67M Buy
126,294
+33,300
+36% +$16.1M 4.75% 2
2023
Q3 		$47.1M Buy
92,994
+1,768
+2% +$942K 4.37% 2
2023
Q2 		$47.6M Sell
91,226
-7,932
-8% -$4.28M 4.16% 3
2023
Q1 		$57.2M Buy
99,158
+5,322
+6% +$3M 4.19% 2
2022
Q4 		$51.7M Buy
93,836
+418
+0.4% +$221K 4.36% 2
2022
Q3 		$47.4M Buy
93,418
+113
+0.1% +$63.2K 3.85% 4
2022
Q2 		$50.7M Sell
93,305
-16,326
-15% -$8.99M 3.11% 11
2022
Q1 		$65.2M Buy
109,631
+10,739
+11% +$6.17M 2.83% 15
2021
Q4 		$66M Sell
98,892
-19,951
-17% -$12.5M 2.51% 12
2021
Q3 		$67.9M Buy
118,843
+3,666
+3% +$2.01M 2.72% 11
2021
Q2 		$58.1M Buy
115,177
+28,825
+33% +$13.6M 2.25% 19
2021
Q1 		$39.4M Buy
86,352
+74,318
+618% +$35.5M 1.5% 25
2020
Q4 		$5.61M Sell
12,034
-38
-0.3% -$17.8K 0.24% 49
2020
Q3 		$5.33M Sell
12,072
-1,575
-12% -$651K 0.23% 47
2020
Q2 		$4.94M Sell
13,647
-912
-6% -$306K 0.25% 42
2020
Q1 		$4.13M Buy
14,559
+149
+1% +$47K 0.27% 45
2019
Q4 		$4.68M Buy
14,410
+1,050
+8% +$318K 0.3% 34
2019
Q3 		$3.89M Buy
+13,360
New +$3.83M 0.29% 35

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Formuepleje A/S's TMO Position: Q2 2026 in Review

Formuepleje A/S reduced its Thermo Fisher Scientific (TMO) stake by 6.9% in Q2 2026, selling an estimated $4.44M and leaving 125,121 shares worth $62.7M. The position accounts for 4.91% of the portfolio, ranked #7.

Formuepleje A/S first reported a position in TMO in Q3 2019 and has held it in 28 quarters since. The position peaked at $109M in Q3 2024. 2,616 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Formuepleje A/S held 125,121 shares of Thermo Fisher Scientific worth $62.7M as of Q2 2026.
  • Formuepleje A/S sold 9,246 Thermo Fisher Scientific shares in Q2 2026, an estimated $4.44M.
  • Thermo Fisher Scientific made up 4.91% of Formuepleje A/S's portfolio in Q2 2026, its #7 holding.
  • Formuepleje A/S first reported a position in Thermo Fisher Scientific in Q3 2019 and has held it in 28 quarters since.
  • Formuepleje A/S's Thermo Fisher Scientific position peaked at $109M in Q3 2024.
  • 2,616 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Formuepleje A/S's 13F filing for Q2 2026, filed 27 Aug 2026.